Iterum Therapeutics Cash from Investing (Quarterly) Insights

Iterum Therapeutics PLC (ITRM)

1.540 0.00 (0.00%) USD | NASDAQ | Apr 30, 16:00

1.53 -0.01 (-0.64%) After-Hours: 20:00

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	13.52M
September 30, 2023	0.36M
June 30, 2023	4.347M
March 31, 2023	5.106M
December 31, 2022	4.378M
September 30, 2022	15.85M
June 30, 2022	-15.86M
March 31, 2022	9.593M
December 31, 2021	-4.466M
September 30, 2021	4.935M
June 30, 2021	-21.14M
March 31, 2021	-33.92M
December 31, 2020	0.00
September 30, 2020	-0.009M

Date	Value
June 30, 2020	-0.002M
March 31, 2020	0.00
December 31, 2019	-0.002M
September 30, 2019	0.025M
June 30, 2019	4.988M
March 31, 2019	35.09M
December 31, 2018	28.75M
September 30, 2018	-17.77M
June 30, 2018	-28.99M
March 31, 2018	9.357M
December 31, 2017	6.446M
September 30, 2017	-3.636M
June 30, 2017	-33.88M
March 31, 2017	-0.518M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-33.92M

Minimum

Mar 2021

15.85M

Maximum

Sep 2022

-0.6475M

Average

0.025M

Median

Sep 2019

Cash from Investing (Quarterly) Benchmarks

Alkermes PLC	-20.98M
Endo International PLC	-11.65M
Jazz Pharmaceuticals PLC	101.80M
Medtronic PLC	-707.00M
Perrigo Co PLC	-22.80M

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-12.84M
Cash from Financing (Quarterly)	0.589M
Free Cash Flow	-39.34M
Free Cash Flow Per Share (Quarterly)	-0.9742
Free Cash Flow Yield	-197.1%